Ocular Therapeutix, Inc. (OCUL)
8.87
-0.63
(-6.63%)
USD |
NASDAQ |
Mar 12, 16:00
8.90
+0.03
(+0.34%)
After-Hours: 20:00
Ocular Therapeutix Shareholders Equity (Quarterly) : 654.31M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Abbott Laboratories | 52.13B |
| EyePoint Plc | 306.11M |
| Quince Therapeutics, Inc. | 1.059M |
| Ernexa Therapeutics, Inc. | 3.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 811.14M |
| Total Liabilities (Quarterly) | 156.83M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 15.39 |
| Net Debt Paydown Yield | -0.01% |